COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,557 Articles (22,400 medRxiv, 8,157 bioRxiv)

Most recent first Previous |  Page 1172: Articles 11711-11720  | Next

Social Capital Dimensions are Differentially Associated with COVID-19 Vaccinations, Masks, and Physical Distancing
Ferwana, I., Varshney, L. R.
10.1101/2021.09.13.21263543 — Posted: 2021-09-16
High Seroconversion Rates Amongst Black and Hispanics With Hematologic Malignancies after SARS-CoV-2 Vaccination
Shapiro, L. C., Thakkar, A., Gali, R., Gonzalez-Lugo, J. D., Bazarbachi, A.-H., Rahman, S., Pradhan, K., Fehn, K., Abreu, M., Kornblum, N., Gritsman, K., Goldfinger, M., Shastri, A., Mantzaris, I., Braunschweig, I., Halmos, B., Verma, A., McCort, M., Bachier-Rodriguez, L., Sica, R. A.
10.1101/2021.09.13.21263365 — Posted: 2021-09-16
Anti-SARS-CoV-2 IgG and IgA antibodies in COVID-19 convalescent plasma do not facilitate antibody-dependent enhance of viral infection.
Clark, N. M., Janaka, S. K., Hartman, W., Stramer, S., Goodhue, E., Weiss, J., Evans, D. T., Connor, J. P.
10.1101/2021.09.14.460394 — Posted: 2021-09-16
A genetic trap in yeast for inhibitors of SARS-CoV-2 main protease
Alalam, H., Sigurdardottir, S., Bourgard, C., Tiukova, I. A., King, R. D., Grötli, M., Sunnerhagen, P.
10.1101/2021.09.14.460411 — Posted: 2021-09-16
Robust clinical detection of SARS-CoV-2 variants by RT-PCR/MALDI-TOF multi-target approach
Hernandez, M. M., Banu, R., Gonzalez-Reiche, A. S., van de Guchte, A., Khan, Z., Shrestha, P., Cao, L., Chen, F., Shi, H., Hanna, A., Alshammary, H., Fabre, S., Amoako, A., Obla, A., Alburquerque, B., Helena Patino, L., Ramirez, J. D., Sebra, R., Gitman, M. R., Nowak, M. D., Cordon-Cardo, C., Schutzbank, T. E., Simon, V., van Bakel, H., Sordillo, E. M., Paniz Mondolfi, A. E.
10.1101/2021.09.09.21263348 — Posted: 2021-09-16
SARS-CoV-2 anti-spike IgG antibody responses after second dose of ChAdOx1 or BNT162b2 in the UK general population
Wei, J., Pouwels, K. B., Stoesser, N., Matthews, P. C., Diamond, I., Studley, R., Rourke, E., Cook, D., Bell, J. I., Newton, J. N., Farrar, J., Howarth, A., Marsden, B. D., Hoosdally, S., Jones, E. Y., Stuart, D. I., Crook, D. W., Peto, T. E. A., Walker, A. S., Eyre, D. W.
10.1101/2021.09.13.21263487 — Posted: 2021-09-16
Synthetic lethality-based prediction of anti-SARS-CoV-2 targets
Pal, L. R., Cheng, K., Nair, N. U., Martin-Sancho, L., Sinha, S., Pu, Y., Riva, L., Yin, X., Schischlik, F., Lee, J. S., Chanda, S. K., Ruppin, E.
10.1101/2021.09.14.460408 — Posted: 2021-09-15
Intronization enhances expression of S-protein and other transgenes challenged by cryptic splicing
Tomberg, K., Antunes, L., Pan, Y., Hepkema, J., Garyfallos, D. A., Mahfouz, A., Bradley, A.
10.1101/2021.09.15.460454 — Posted: 2021-09-15
Molecular architecture of SARS-CoV-2 envelope by integrative modeling
Pezeshkian, W., Grunewald, F., Narykov, O., Lu, S., Wassenaar, T., Marrink, S.-J. J., Korkin, D.
10.1101/2021.09.15.459697 — Posted: 2021-09-15
Phylodynamic Pattern of Genetic Clusters, Paradigm Shift on Spatio-temporal Distribution of Clades, and Impact of Spike Glycoprotein Mutations of SARS-CoV-2 Isolates from India
Subramanian, S., Kitambi, S.
10.1101/2021.09.15.460506 — Posted: 2021-09-15

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).